-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on CVS Health, Raises Price Target to $110

Benzinga·05/20/2026 13:04:29
Listen to the news
Mizuho analyst Ann Hynes maintains CVS Health (NYSE:CVS) with a Outperform and raises the price target from $102 to $110.